| Dr Jonathan Michael Mccrea, MD | |
|
121 S Saint Louis Blvd, South Bend, IN 46617-2924 | |
| (574) 233-3123 | |
| (574) 233-3125 |
| Full Name | Dr Jonathan Michael Mccrea |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 17 Years |
| Location | 121 S Saint Louis Blvd, South Bend, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700048923 | NPI | - | NPPES |
| 201155790 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 01072365A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Joseph Regional Medical Center | Mishawaka, IN | Hospital |
| Saint Joseph Regional Medical Center - Plymouth | Plymouth, IN | Hospital |
| Unity Medical And Surgical Hospital | Mishawaka, IN | Hospital |
| St Joseph Mercy Hospital | Ann arbor, MI | Hospital |
| St Joe Mercy Hospital System Livonia | Livonia, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Huron Valley Radiology Pc | 2961466859 | 72 |
| X-ray Consultants Inc | 7315859832 | 17 |
News Archive
Stoptober is a UK-wide campaign to get the nation to quit smoking. We, the British Skin Foundation, are asking that Stoptober participants get a friends, family & colleagues to sponsor your efforts and raise some money for skin disease research at the same time.
Guidant Corporation, Columbia University and Stony Brook University will collaborate to study a new gene and cell therapy that may ultimately provide better understanding of how genetically-engineered cells can help pace the heart.
Scientific insights that expand on the teachings of Mendel, Watson and Crick, and underpinnings of the Human Genome Project are moving drug companies along the path to development of new medicines based on deeper insights into how factors other than the genetic code influence health and disease. That's the topic of the cover story in the current edition of Chemical & Engineering News (C&EN), the weekly newsmagazine of the American Chemical Society (ACS), the world's largest scientific society.
Fight for Sight is funding research by scientists from universities and hospitals in Birmingham and London using artificial intelligence to extract ‘hidden' information from retinal images of patients with a rare eye condition called birdshot uveitis.
CardioVascular BioTherapeutics, Inc. , announced today that it has dosed the first patient in North America (NA) as part of its ACORD Phase II clinical trial to treat patients with severe coronary heart disease.
› Verified 2 days ago
| Entity Name | X-ray Consultants Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770536815 PECOS PAC ID: 7315859832 Enrollment ID: O20031118000632 |
News Archive
Stoptober is a UK-wide campaign to get the nation to quit smoking. We, the British Skin Foundation, are asking that Stoptober participants get a friends, family & colleagues to sponsor your efforts and raise some money for skin disease research at the same time.
Guidant Corporation, Columbia University and Stony Brook University will collaborate to study a new gene and cell therapy that may ultimately provide better understanding of how genetically-engineered cells can help pace the heart.
Scientific insights that expand on the teachings of Mendel, Watson and Crick, and underpinnings of the Human Genome Project are moving drug companies along the path to development of new medicines based on deeper insights into how factors other than the genetic code influence health and disease. That's the topic of the cover story in the current edition of Chemical & Engineering News (C&EN), the weekly newsmagazine of the American Chemical Society (ACS), the world's largest scientific society.
Fight for Sight is funding research by scientists from universities and hospitals in Birmingham and London using artificial intelligence to extract ‘hidden' information from retinal images of patients with a rare eye condition called birdshot uveitis.
CardioVascular BioTherapeutics, Inc. , announced today that it has dosed the first patient in North America (NA) as part of its ACORD Phase II clinical trial to treat patients with severe coronary heart disease.
› Verified 2 days ago
| Entity Name | Northern Indiana Magnetic Resonance Center, Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447252200 PECOS PAC ID: 6709780802 Enrollment ID: O20031120000842 |
News Archive
Stoptober is a UK-wide campaign to get the nation to quit smoking. We, the British Skin Foundation, are asking that Stoptober participants get a friends, family & colleagues to sponsor your efforts and raise some money for skin disease research at the same time.
Guidant Corporation, Columbia University and Stony Brook University will collaborate to study a new gene and cell therapy that may ultimately provide better understanding of how genetically-engineered cells can help pace the heart.
Scientific insights that expand on the teachings of Mendel, Watson and Crick, and underpinnings of the Human Genome Project are moving drug companies along the path to development of new medicines based on deeper insights into how factors other than the genetic code influence health and disease. That's the topic of the cover story in the current edition of Chemical & Engineering News (C&EN), the weekly newsmagazine of the American Chemical Society (ACS), the world's largest scientific society.
Fight for Sight is funding research by scientists from universities and hospitals in Birmingham and London using artificial intelligence to extract ‘hidden' information from retinal images of patients with a rare eye condition called birdshot uveitis.
CardioVascular BioTherapeutics, Inc. , announced today that it has dosed the first patient in North America (NA) as part of its ACORD Phase II clinical trial to treat patients with severe coronary heart disease.
› Verified 2 days ago
| Entity Name | Saint Joseph Regional Medical Center- Plymouth Campus Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538585187 PECOS PAC ID: 9537071337 Enrollment ID: O20031223000588 |
News Archive
Stoptober is a UK-wide campaign to get the nation to quit smoking. We, the British Skin Foundation, are asking that Stoptober participants get a friends, family & colleagues to sponsor your efforts and raise some money for skin disease research at the same time.
Guidant Corporation, Columbia University and Stony Brook University will collaborate to study a new gene and cell therapy that may ultimately provide better understanding of how genetically-engineered cells can help pace the heart.
Scientific insights that expand on the teachings of Mendel, Watson and Crick, and underpinnings of the Human Genome Project are moving drug companies along the path to development of new medicines based on deeper insights into how factors other than the genetic code influence health and disease. That's the topic of the cover story in the current edition of Chemical & Engineering News (C&EN), the weekly newsmagazine of the American Chemical Society (ACS), the world's largest scientific society.
Fight for Sight is funding research by scientists from universities and hospitals in Birmingham and London using artificial intelligence to extract ‘hidden' information from retinal images of patients with a rare eye condition called birdshot uveitis.
CardioVascular BioTherapeutics, Inc. , announced today that it has dosed the first patient in North America (NA) as part of its ACORD Phase II clinical trial to treat patients with severe coronary heart disease.
› Verified 2 days ago
| Entity Name | Saint Joseph Regional Medical Center-south Bend Campus Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841245594 PECOS PAC ID: 3476451790 Enrollment ID: O20031223000724 |
News Archive
Stoptober is a UK-wide campaign to get the nation to quit smoking. We, the British Skin Foundation, are asking that Stoptober participants get a friends, family & colleagues to sponsor your efforts and raise some money for skin disease research at the same time.
Guidant Corporation, Columbia University and Stony Brook University will collaborate to study a new gene and cell therapy that may ultimately provide better understanding of how genetically-engineered cells can help pace the heart.
Scientific insights that expand on the teachings of Mendel, Watson and Crick, and underpinnings of the Human Genome Project are moving drug companies along the path to development of new medicines based on deeper insights into how factors other than the genetic code influence health and disease. That's the topic of the cover story in the current edition of Chemical & Engineering News (C&EN), the weekly newsmagazine of the American Chemical Society (ACS), the world's largest scientific society.
Fight for Sight is funding research by scientists from universities and hospitals in Birmingham and London using artificial intelligence to extract ‘hidden' information from retinal images of patients with a rare eye condition called birdshot uveitis.
CardioVascular BioTherapeutics, Inc. , announced today that it has dosed the first patient in North America (NA) as part of its ACORD Phase II clinical trial to treat patients with severe coronary heart disease.
› Verified 2 days ago
| Entity Name | Huron Valley Radiology Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659398519 PECOS PAC ID: 2961466859 Enrollment ID: O20220927000236 |
News Archive
Stoptober is a UK-wide campaign to get the nation to quit smoking. We, the British Skin Foundation, are asking that Stoptober participants get a friends, family & colleagues to sponsor your efforts and raise some money for skin disease research at the same time.
Guidant Corporation, Columbia University and Stony Brook University will collaborate to study a new gene and cell therapy that may ultimately provide better understanding of how genetically-engineered cells can help pace the heart.
Scientific insights that expand on the teachings of Mendel, Watson and Crick, and underpinnings of the Human Genome Project are moving drug companies along the path to development of new medicines based on deeper insights into how factors other than the genetic code influence health and disease. That's the topic of the cover story in the current edition of Chemical & Engineering News (C&EN), the weekly newsmagazine of the American Chemical Society (ACS), the world's largest scientific society.
Fight for Sight is funding research by scientists from universities and hospitals in Birmingham and London using artificial intelligence to extract ‘hidden' information from retinal images of patients with a rare eye condition called birdshot uveitis.
CardioVascular BioTherapeutics, Inc. , announced today that it has dosed the first patient in North America (NA) as part of its ACORD Phase II clinical trial to treat patients with severe coronary heart disease.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jonathan Michael Mccrea, MD 121 S Saint Louis Blvd, South Bend, IN 46617-2924 Ph: (574) 233-3123 | Dr Jonathan Michael Mccrea, MD 121 S Saint Louis Blvd, South Bend, IN 46617-2924 Ph: (574) 233-3123 |
News Archive
Stoptober is a UK-wide campaign to get the nation to quit smoking. We, the British Skin Foundation, are asking that Stoptober participants get a friends, family & colleagues to sponsor your efforts and raise some money for skin disease research at the same time.
Guidant Corporation, Columbia University and Stony Brook University will collaborate to study a new gene and cell therapy that may ultimately provide better understanding of how genetically-engineered cells can help pace the heart.
Scientific insights that expand on the teachings of Mendel, Watson and Crick, and underpinnings of the Human Genome Project are moving drug companies along the path to development of new medicines based on deeper insights into how factors other than the genetic code influence health and disease. That's the topic of the cover story in the current edition of Chemical & Engineering News (C&EN), the weekly newsmagazine of the American Chemical Society (ACS), the world's largest scientific society.
Fight for Sight is funding research by scientists from universities and hospitals in Birmingham and London using artificial intelligence to extract ‘hidden' information from retinal images of patients with a rare eye condition called birdshot uveitis.
CardioVascular BioTherapeutics, Inc. , announced today that it has dosed the first patient in North America (NA) as part of its ACORD Phase II clinical trial to treat patients with severe coronary heart disease.
› Verified 2 days ago
Dr. Scott H Wolf, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 211 N Eddy St, South Bend, IN 46617 Phone: 574-237-9203 Fax: 574-237-9311 | |
Dr. Vu H Nguyen, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 121 S Saint Louis Blvd, South Bend, IN 46617 Phone: 574-233-3123 Fax: 574-233-3125 | |
Dr. Michael John Hall, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 100 Navarre Pl Ste 5500, South Bend, IN 46601 Phone: 574-647-5200 Fax: 574-647-5210 | |
Dr. Brett A Stephens, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 121 S Saint Louis Blvd, South Bend, IN 46617 Phone: 574-233-3123 Fax: 574-233-3125 | |
Dr. David A Cory, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 121 S Saint Louis Blvd, South Bend, IN 46617 Phone: 574-233-3123 Fax: 574-233-3125 | |
Dr. Thomas A Bowers, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 211 N Eddy St, South Bend, IN 46617 Phone: 574-237-9203 Fax: 574-237-9311 | |
Samuel Mcgrath, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 621 Memorial Dr Ste 100, South Bend, IN 46601 Phone: 574-647-1100 |